Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

NCT05406206 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Carcinoma
Liver Metastasis Colon Cancer

Interventions

DRUG: Fruquintinib
PROCEDURE: Hepatic Arterial Infusion Chemotherapy

Sponsor

Peking University Cancer Hospital & Institute